"Osteoclasts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.
| Descriptor ID |
D010010
|
| MeSH Number(s) |
A11.329.372.700 A11.627.482.700
|
| Concept/Terms |
Odontoclasts- Odontoclasts
- Cementoclast
- Odontoclast
- Cementoclasts
|
Below are MeSH descriptors whose meaning is more general than "Osteoclasts".
Below are MeSH descriptors whose meaning is more specific than "Osteoclasts".
This graph shows the total number of publications written about "Osteoclasts" by people in this website by year, and whether "Osteoclasts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 5 | 2 | 7 |
| 2014 | 3 | 1 | 4 |
| 2015 | 1 | 3 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 3 | 5 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 2 | 3 |
| 2024 | 0 | 3 | 3 |
| 2025 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteoclasts" by people in Profiles.
-
Anti-transforming growth factor-? treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I. J Bone Miner Res. 2025 Jun 25; 40(7):881-890.
-
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization. Cell Genom. 2025 Jul 09; 5(7):100888.
-
The role of PD-1/PD-L1 in overshooting osteoclastogenesis in periprosthetic joint infections. Commun Biol. 2025 May 22; 8(1):786.
-
ATRX silences Cartpt expression in osteoblastic cells during skeletal development. J Clin Invest. 2025 Jan 02; 135(1).
-
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects. Bone Res. 2024 Sep 05; 12(1):52.
-
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024 Jul 11; 187(14):3690-3711.e19.
-
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis. Nat Commun. 2024 Mar 16; 15(1):2384.
-
Murine IRF8 Mutation Offers New Insight into Osteoclast and Root Resorption. J Dent Res. 2024 03; 103(3):318-328.
-
Cutaneous Atypical Fibroxanthoma With Osteoclast-Like Giant Cell: A Rare but Diagnostic Pitfall. Am J Dermatopathol. 2023 10 01; 45(10):704-707.
-
Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022; 13:936159.